BSE Live
Apr 13, 16:01Prev. Close
734.55
Open Price
709.00
Bid Price (Qty.)
714.60 (805)
Offer Price (Qty.)
760.00 (46)
NSE Live
Apr 13, 15:44Prev. Close
732.00
Open Price
704.00
Bid Price (Qty.)
719.25 (14)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Albert David (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 28.95 | 28.85 | 21.54 | 27.24 | 22.21 | |
| Net CashFlow From Operating Activities | 30.09 | 31.96 | 30.01 | 19.87 | 68.21 | |
| Net Cash Used In Investing Activities | -20.00 | -19.16 | -11.03 | -36.60 | -38.34 | |
| Net Cash Used From Financing Activities | -10.17 | -17.09 | -4.56 | 6.69 | -17.93 | |
| Foreign Exchange Gains / Losses | 0.08 | -0.01 | 0.20 | 0.26 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.00 | -4.30 | 14.63 | -9.79 | 11.95 | |
| Cash And Cash Equivalents Begin of Year | 6.41 | 10.71 | -3.92 | 5.87 | 9.77 | |
| Cash And Cash Equivalents End Of Year | 6.42 | 6.41 | 10.71 | -3.92 | 21.72 |
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth